XML 46 R33.htm IDEA: XBRL DOCUMENT v3.23.2
FINANCIAL INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Carrying Amount and Fair Value of the Long-Term Debt
At June 30, 2023, the carrying values and fair values of the following financial assets and liabilities were as follows (in thousands):
Carrying ValueFair Value Measurements Using
Level 1Level 2Level 3
Financial Assets and Financial Liabilities Measured at Fair Value on a Recurring Basis:
Financial Assets:
Equity investments$15,877 $— $— $15,877 
Convertible notes receivable$12,062 $— $— $12,062 
Financial Liabilities:
   Acquisition-related contingent consideration$21,482 $— $— $21,482 
Financial Liabilities Measured at Amortized Cost:
Term loan A facility due March 2028$145,686 $— $146,452 $— 
   0.750% convertible senior notes due 2025 (1)
$397,360 $— $372,566 $— 
   3.375% convertible senior notes due 2024
$8,641 $— $8,641 $— 
(1) The closing price of the Company’s common stock as reported on the Nasdaq Global Select Market was $40.07 per share at June 30, 2023 compared to a conversion price of $71.78 per share. At June 30, 2023, as the conversion price was above the stock price, the requirements for conversion have not been met. The maximum conversion premium that could have been due on the 2025 Notes is 5.6 million shares of the Company’s common stock, which assumes no increase in the conversion rate for certain corporate events.
Schedule of Investments without Readily Determinable Fair Value The following investments have no readily determinable fair value and are recorded at cost minus impairment, if any, plus or minus observable price changes of identical or similar investments (in thousands):
Equity InvestmentsConvertible Notes ReceivableTotal
Balance at December 31, 2021
$14,127 $4,132 $18,259 
   Purchases11,750 1,250 13,000 
   Impairment(10,000)— (10,000)
   Foreign currency adjustments— (67)(67)
Balance at December 31, 2022
15,877 5,315 21,192 
   Purchases— 6,758 6,758 
   Foreign currency adjustments— (11)(11)
Balance at June 30, 2023
$15,877 $12,062 $27,939 
Schedule of Key Assumptions used in the Valuation of Contingent Consideration
The following table includes the key assumptions used in the valuation of the Company’s contingent consideration:
Assumption
Flexion Ranges
Utilized as of
June 30, 2023
Discount rates
9.4% to 11.0%
Probabilities of payment for regulatory milestones
0% to 12.5%
Projected years of payment for regulatory and commercial milestones
2030
Schedule of Change in Contingent Consideration Recorded at Fair Value using Level 3 Measurements The change in the Company’s contingent consideration recorded at fair value using Level 3 measurements is as follows (in thousands):
Contingent Consideration
Fair Value
Balance at December 31, 2021
$57,598 
Fair value adjustments and accretion(29,476)
Balance at December 31, 2022
28,122 
   Fair value adjustments and accretion(6,640)
Balance at June 30, 2023
$21,482 
Schedule of Short-Term Investments
The following summarizes the Company’s short-term and noncurrent available-for-sale investments at June 30, 2023 and December 31, 2022 (in thousands):
June 30, 2023 Investments
CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
(Level 2)
Current:
Asset-backed securities$5,972 $— $(16)$5,956 
Commercial paper49,007 — (99)48,908 
U.S. federal agency bonds64,789 — (314)64,475 
U.S. government bonds14,697 — (80)14,617 
          Total$134,465 $— $(509)$133,956 
December 31, 2022 Investments
CostGross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
(Level 2)
Current:
Asset-backed securities$6,836 $— $(3)$6,833 
Commercial paper134,423 23 (386)134,060 
U.S. federal agency bonds41,971 — (337)41,634 
U.S. government bonds2,003 — (18)1,985 
Subtotal$185,233 $23 $(744)$184,512 
Noncurrent:
U.S. federal agency bonds22,783 (66)22,719 
U.S. government bonds14,499 — (9)14,490 
Subtotal37,282 (75)37,209 
          Total$222,515 $25 $(819)$221,721